Search Results - "Stansborough, Romany"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Proteasome inhibitor-induced gastrointestinal toxicity by Stansborough, Romany L., Gibson, Rachel J.

    “…PURPOSE OF REVIEWGastrointestinal toxicities are commonly reported following treatment with proteasome inhibitors. The first-generation proteasome inhibitor,…”
    Get full text
    Journal Article
  2. 2

    Matrix metalloproteinase expression is altered in the small and large intestine following fractionated radiation in vivo by Stansborough, Romany L., Al-Dasooqi, Noor, Bateman, Emma H., Bowen, Joanne M., Keefe, Dorothy M. K., Logan, Richard M., Yeoh, Ann S. J., Yeoh, Eric E. K., Stringer, Andrea M., Gibson, Rachel J.

    Published in Supportive care in cancer (01-11-2018)
    “…Purpose Radiotherapy-induced gut toxicity (RIGT) is associated with significant diarrhoea, pain and rectal bleeding. Matrix metalloproteinases (MMPs) have been…”
    Get full text
    Journal Article
  3. 3

    Radiotherapy-induced gut toxicity: Involvement of matrix metalloproteinases and the intestinal microvasculature by Stansborough, Romany L., Al-dasooqi, Noor, Bateman, Emma H., Keefe, Dorothy M. K., Gibson, Rachel J.

    Published in International journal of radiation biology (03-05-2016)
    “…Purpose To review the literature surrounding the involvement of the endothelium and matrix metalloproteinases (MMP) in radiotherapy-induced gut toxicity (RIGT)…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report by Coller, Janet K., Bowen, Joanne M., Ball, Imogen A., Wardill, Hannah R., van Sebille, Ysabella Z. A., Stansborough, Romany L., Lightwala, Zenab, Wignall, Anthony, Shirren, Joseph, Secombe, Kate, Gibson, Rachel J.

    Published in Cancer chemotherapy and pharmacology (01-02-2017)
    “…Purpose Irinotecan-induced gut toxicity is mediated in part by Toll-Like receptor 4 (TLR4) signalling. The primary purpose of this preclinical study was to…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics by Van Sebille, Ysabella Z. A., Stansborough, Romany, Wardill, Hannah R., Bateman, Emma, Gibson, Rachel J., Keefe, Dorothy M.

    Published in Current Oncology Reports (01-11-2015)
    “…Chemotherapy-induced mucositis is a common condition caused by the breakdown of the mucosal barrier. Symptoms can include pain, vomiting and diarrhoea, which…”
    Get full text
    Journal Article Book Review
  8. 8

    Irinotecan disrupts tight junction proteins within the gut: Implications for chemotherapy-induced gut toxicity by Wardill, Hannah R, Bowen, Joanne M, Al-Dasooqi, Noor, Sultani, Masooma, Bateman, Emma, Stansborough, Romany, Shirren, Joseph, Gibson, Rachel J

    Published in Cancer biology & therapy (01-02-2014)
    “…Chemotherapy for cancer causes significant gut toxicity, leading to severe clinical manifestations and an increased economic burden. Despite much research,…”
    Get full text
    Journal Article
  9. 9